Search - tctmd.com

Displaying 381 - 400 of 465

Sort: Relevancy | Date

News Daily News

As Stroke Rates Fall, Questions Mount for Embolic Protection Devices in TAVR

Michael O'Riordan

March 14, 2016

News Daily News

New Analysis Fails to Find Link Between Successful CTO PCI and Lower Mortality

Todd Neale

March 06, 2016

News Daily News

FDA Gives Greenlight for Low-Risk TAVR Study With CoreValve

Michael O'Riordan

February 21, 2016

News Daily News

Covered Stents Show Promise in Patients With Aortic Coarctation: COAST II

L.A. McKeown

February 21, 2016

News Daily News

Subclinical Changes in Valve Hemodynamics Observed in TAVR Patients

Michael O'Riordan

February 08, 2016

News Daily News

Year in Review: Physicians Select the Most Important News of 2015, in Interventional Cardiology and Beyond

December 23, 2015

News Industry News

BioVentrix Announces 30th Clinical Case Milestone for Revivent-TC™ Technology

December 13, 2015

News Industry News

BioVentrix Announces Milestone Achievement of its First Interventional Heart Failure Procedure for LV Volume Reduction in a Pre-Clinical Mode

December 08, 2015

News Daily News

Report Provides Snapshot of Initial Commercial TAVR Experience

Todd Neale

November 30, 2015

News Industry News

Study Shows Initial Aortic Valve Replacement In Asymptomatic Patients With Severe Aortic Stenosis May be Viable Treatment Option

October 15, 2015

News Industry News

Edwards SAPIEN 3 Valve Demonstrates High Survival And Low Stroke Rate At 1 Year

October 15, 2015

News Conference News TCT 2015

MISTRAL-C: Cerebral Protection in TAVR May Reduce New Lesions

October 14, 2015

News Industry News

First US Multi-center Study Finds Unprotected TAVR Procedures Produce New Brain Lesions in Nearly All Cases

October 14, 2015

News Conference News TCT 2015

Current State of Percutaneous Valve Therapies for Use in Congestive HF Explored

October 13, 2015

News Conference News TCT 2015

Global TAVR Market Poised to Exceed DES Market by 2025

October 11, 2015

News Conference News TCT 2015

Asian TAVR Registry Shows Good Procedural and Clinical Results

October 11, 2015

News Industry News

Boston Scientific Announces Scheduled Presentations At TCT 2015

October 08, 2015

News Industry News

Sorin Group Starts First Randomized, Controlled Trial Comparing the Perceval Sutureless Valve to Standard Bioprostheses

October 06, 2015

News Daily News

In the Early Days of TAVR, No Mortality Penalty for Patients Treated Outside of Trial Centers

October 01, 2015

News Industry News

HeartMate 3™ CE Mark Trial Meets Primary Endpoint

September 28, 2015

Advertisement

As Stroke Rates Fall, Questions Mount for Embolic Protection Devices in TAVR

New Analysis Fails to Find Link Between Successful CTO PCI and Lower Mortality

FDA Gives Greenlight for Low-Risk TAVR Study With CoreValve

Covered Stents Show Promise in Patients With Aortic Coarctation: COAST II

Subclinical Changes in Valve Hemodynamics Observed in TAVR Patients

Year in Review: Physicians Select the Most Important News of 2015, in Interventional Cardiology and Beyond

BioVentrix Announces 30th Clinical Case Milestone for Revivent-TC™ Technology

BioVentrix Announces Milestone Achievement of its First Interventional Heart Failure Procedure for LV Volume Reduction in a Pre-Clinical Mode

Report Provides Snapshot of Initial Commercial TAVR Experience

Study Shows Initial Aortic Valve Replacement In Asymptomatic Patients With Severe Aortic Stenosis May be Viable Treatment Option

Edwards SAPIEN 3 Valve Demonstrates High Survival And Low Stroke Rate At 1 Year

MISTRAL-C: Cerebral Protection in TAVR May Reduce New Lesions

First US Multi-center Study Finds Unprotected TAVR Procedures Produce New Brain Lesions in Nearly All Cases

Current State of Percutaneous Valve Therapies for Use in Congestive HF Explored

Global TAVR Market Poised to Exceed DES Market by 2025

Asian TAVR Registry Shows Good Procedural and Clinical Results

Boston Scientific Announces Scheduled Presentations At TCT 2015

Sorin Group Starts First Randomized, Controlled Trial Comparing the Perceval Sutureless Valve to Standard Bioprostheses

In the Early Days of TAVR, No Mortality Penalty for Patients Treated Outside of Trial Centers

HeartMate 3™ CE Mark Trial Meets Primary Endpoint

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content